Metabolic cleavage of cell-penetrating peptides in contact with epithelial models:: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58)

被引:62
作者
Tréhin, R
Nielsen, HM
Jahnke, HG
Beck-Sickinger, AG
Merkle, HP
机构
[1] ETH, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Drug Formulat & Delivery Grp, CH-8057 Zurich, Switzerland
[2] Danish Univ Pharmaceut Sci, Dept Pharmaceut, DK-2100 Copenhagen, Denmark
[3] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany
关键词
cell-penetrating peptides; epithelial delivery; human calcitonin; metabolic cleavage; penetratin; Tat;
D O I
10.1042/BJ20040238
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We assessed the metabolic degradation kinetics and cleavage patterns of some selected CPP (cell-penetrating peptides) after incubation with confluent epithelial models. Synthesis of N-terminal CF [5 (6)-carboxyfluorescein]-labelled CPP, namely hCT (human calcitonin)-derived sequences, Tat(47-57) and penetratin(4358), was through Fmoc (fluoren-9-ylmethoxycarbonyl) chemistry. Metabolic degradation kinetics of the tested CPP in contact with three cell-cultured epithelial models, MDCK (Madin-Darby canine kidney), Calu-3 and TR146, was evaluated by reversed-phase HPLC. Identification of the resulting metabolites of CF-hCT(9-32) was through reversed-phase HPLC fractionation and peak allocation by MALDI-TOF-MS (matrix-assisted laser-desorption ionization-time-of-flight mass spectrometry) or direct MALDI-TOF-MS of incubates. Levels of proteolytic activity varied highly between the investigated epithelial models and the CPP. The Calu-3 model exhibited the highest proteolytic activity. The patterns of metabolic cleavage of hCT(9-32) were similar in all three models. Initial cleavage of this peptide occurred at the N-terminal domain, possibly by endopeptidase activity yielding both the N- and the C-terminal counterparts. Further metabolic degradation was by aminopeptidase, endopeptidase and/or carboxypeptidase activities. In conclusion, when in contact with epithelial models, the studied CPP were subject to efficient metabolism, a prerequisite of cargo release on the one hand, but with potential for premature cleavage and loss of the cargo as well on the other. The results, particularly on hCT(9-32), may be used as a template to suggest structural modifications towards improved CPP performance.
引用
收藏
页码:945 / 956
页数:12
相关论文
共 52 条
[1]   Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions [J].
Astriab-Fisher, A ;
Sergueev, D ;
Fisher, M ;
Shaw, BR ;
Juliano, RL .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :744-754
[2]   Localization of aminopeptidase activity in freshly excised human skin: Direct visualization by confocal laser scanning microscopy [J].
Boderke, P ;
Merkle, HP ;
Cullander, C ;
Ponec, M ;
Bodde, HE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (01) :83-86
[3]  
Boderke P, 1998, J Investig Dermatol Symp Proc, V3, P180
[4]   Taking the cell by stealth or storm? Protein Transduction Domains (PTDs) as versatile vectors for delivery [J].
Bogoyevitch, MA ;
Kendrick, TS ;
Ng, DCH ;
Barr, RK .
DNA AND CELL BIOLOGY, 2002, 21 (12) :879-894
[5]   THE MADIN DARBY CANINE KIDNEY (MDCK) EPITHELIAL-CELL MONOLAYER AS A MODEL CELLULAR-TRANSPORT BARRIER [J].
CHO, MJ ;
THOMPSON, DP ;
CRAMER, CT ;
VIDMAR, TJ ;
SCIESZKA, JF .
PHARMACEUTICAL RESEARCH, 1989, 6 (01) :71-77
[6]   In vitro uptake and stability study of pVEC and its all-D analog [J].
Elmquist, A ;
Langel, Ü .
BIOLOGICAL CHEMISTRY, 2003, 384 (03) :387-393
[7]   VE-cadherin-derived cell-penetrating peptide, pVEC, with carrier functions [J].
Elmquist, A ;
Lindgren, M ;
Bartfai, T ;
Langel, U .
EXPERIMENTAL CELL RESEARCH, 2001, 269 (02) :237-244
[8]   REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION (RT-PCR) PHENOTYPIC ANALYSIS OF CELL-CULTURES OF HUMAN TRACHEAL EPITHELIUM, TRACHEOBRONCHIAL GLANDS, AND LUNG CARCINOMAS [J].
FINKBEINER, WE ;
CARRIER, SD ;
TERESI, CE .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1993, 9 (05) :547-556
[9]   A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides [J].
Fischer, R ;
Köhler, K ;
Fotin-Mleczek, M ;
Brock, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) :12625-12635
[10]   Oral controlled release technology for peptides: Status and future prospects [J].
Fix, JA .
PHARMACEUTICAL RESEARCH, 1996, 13 (12) :1760-1764